Collection of biological specimens

OTHER2 trials

Sponsors

Northwestern University, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions

Gastrointestinal CancerHead and Neck CancerLung CancerNasal Polyps

Phase 2

Anti-Inflammatory Agent in Sinusitis

CompletedNCT02874144

Northwestern UniversityNasal Polyps

Start: 2016-06-20End: 2020-08-10Updated: 2022-05-25

Unknown Phase

Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

RecruitingNCT05995821

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsGastrointestinal Cancer, Head and Neck Cancer, Lung Cancer

Start: 2016-08-25End: 2028-08-25Target: 1250Updated: 2026-08-06

Related Papers

Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study.

2026-07-23

Abstract 110: Clinical utility of landmark ctDNA molecular response as an early indicator of immunotherapy outcomes in lung cancer.

Cancer Research2026-04-03

Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer

2026-02-23

Abstract 3772: Leveraging the cfDNA fragmentome to predict immunotherapy response

Cancer Research2025-04-211 citations